EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study

Cuimei Wei iD, Changchun Cao, Zengxin Xu, Gang Chen, Wenjing Liu, Miao Zhang, Haofei Hu iD, Shanghua Xu

PLOS One · 05.06.2026 · 21 (6) · e0350633

DOI: 10.1371/journal.pone.0350633 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS One, online erschienen am 05.06.2026. Verfasst von Cuimei Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanping First Hospital Affiliated to Fujian Medical University Nanping Fujian Province, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2, Triglycerides, Glycated Hemoglobin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanming Project of Medicine in Shenzen Municipality, Clinical Research Fund of Guangdong Medical Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging evidence suggests that the triglyceride-glycated hemoglobin index (TyH-i) may be a novel predictor of type 2 diabetes (T2D) risk. However, in patients diagnosed with NAFLD, the precise link between TyH-i and T2D is still not well elucidated. Currently, the literature lacks sufficient research on how this index affects the incidence of diabetes in the NAFLD population, highlighting a significant gap in our understanding of the interactions between these metabolic conditions. This research seeks to evaluate the association between the TyH-i and diabetes risk, as well as to investigate its predictive capability in patients with NAFLD concerning the triglyceride-glucose index (TyG-i).

Methods

Based on the data of 2741 participants who had no diabetes at baseline and suffered from NAFLD, leveraging a nationwide retrospective cohort, we derived the TyH-i as the natural logarithm of [HbA1c (%) × fasting TG (mg/dL) ÷ 2].To assess the relationship between TyH-i and the risk of developing T2D, a Cox proportional hazards regression model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI). Furthermore, the nonlinear correlations between them were also investigated using the restricted cubic spline model. We gauged the relative discriminatory capacity of TyH-i versus TyG-i by constructing time-dependent receiver-operating characteristic (ROC) plots and comparing the corresponding areas under the curve (AUC) with their 95% CI.

Results

In a median follow-up duration of 5.21 years, incident diabetes was recorded in 223 individuals. The multivariable-adjusted analysis revealed that each unit increase in TyH-i corresponds to a 46% elevation in diabetes risk (HR: 1.75; 95%CI: 1.28-2.41; P = 0.0005). Additionally, a U-shaped relationship was identified between TyH-i levels and the occurrence of type 2 diabetes. Specifically, TyH-i values below 4.95 displayed a notable inverse association with the risk of type 2 diabetes (HR: 0.20, 95%CI: 0.05-0.78, P = 0.0206). Conversely, an elevation in TyH-i levels beyond this threshold was linked to a higher risk of developing type 2 diabetes (HR: 2.01, 95% CI: 1.45-2.39, P < 0.0001). Furthermore, the findings indicate that the Youden Index for both TyH-i and TyG-i is nearly identical, implying that TyH-i may serve as a valid marker for diabetes diagnosis.

Conclusion

Among the patient population suffering from NAFLD, the initial TyH-i level demonstrated a U-shaped correlation with the emergence of type 2 diabetes. This indicated inflection point can act as a practical clinical threshold, allowing differentiation between individuals at low and high risk. The findings imply that keeping TyH-i close to this inflection may play a role in mitigating the progression to diabetes among NAFLD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2TriglyceridesGlycated HemoglobinHumansLongitudinal StudiesFemaleMaleMiddle AgedRisk FactorsBlood GlucoseRetrospective StudiesProportional Hazards ModelsAdult

Substanzen

TriglyceridesGlycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Cardiology, Nanping First Hospital Affiliated to Fujian Medical University Nanping Fujian Province, China.
  • Department of Geriatrics, Shenzhen Second People's Hospital, Shenzhen, Guangdong Province, China.
  • Department of Rehabilitation, Shenzhen Second People's Hospital, Shenzhen Second People's Hospital Dapeng Hospital, Shenzhen, Guangdong Province, China.
  • Bagualing Community Health Service Center, Shenzhen Futian District Second People's Hospital, Shenzhen, Guangdong Province, China.
  • Department of Nephrology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, China.

ORCID-Profile: Cuimei Wei, Haofei Hu

Förderung

  • Sanming Project of Medicine in Shenzen Municipality
  • Clinical Research Fund of Guangdong Medical Association

Zitieren

APA

Wei, C., Cao, C., Xu, Z., Chen, G., Liu, W., Zhang, M., Hu, H., & Xu, S. (2026). Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study. PLOS One, 21(6), e0350633. https://doi.org/10.1371/journal.pone.0350633

Vancouver

Wei C, Cao C, Xu Z, Chen G, Liu W, Zhang M, et al. Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study. PLOS One. 2026;21(6):e0350633. doi:10.1371/journal.pone.0350633

BibTeX
@article{Wei2026,
  author = {Wei, Cuimei and Cao, Changchun and Xu, Zengxin and Chen, Gang and Liu, Wenjing and Zhang, Miao and Hu, Haofei and Xu, Shanghua},
  title = {Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0350633},
  doi = {10.1371/journal.pone.0350633}
}
Kostenlos starten →